Word

SOLMAB

Status

Dead

Status Code

606

Status Date

Monday, March 16, 2020

Serial Number

88315717

Mark Type

4000

Filing Date

Tuesday, February 26, 2019

Published for Opposition

Tuesday, June 18, 2019

Abandoned Date

Monday, March 16, 2020

Trademark Owner History

Solmab, Inc. - Owner At Publication

Classifications

1 Diagnostic reagents for scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagents for chemical analysis, other than for medical or veterinary purposes; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in infectious disease research

5 Antibody-based pharmaceutical products for use in the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, viral and infectious diseases, cancer, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes, contraceptives and hemolytic diseases and disorders; Antibody-based pharmaceutical preparations, namely, cholesterol reducing preparations, osteoporosis prevention preparations, oncological preparations for the prevention and treatment of cancer, dermatological preparations, urological preparations, ophthalmologic preparations, preparations for the treatment of damaged tissue and skin, contraceptives and gynecological estrogen preparations; Antibody-based pharmaceuticals, namely, anti-infectives; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids, including for microorganisms; Drug delivery agents consisting of compounds that facilitate delivery of antibody-based pharmaceuticals; Antibody-based antibacterial pharmaceuticals; Antibody-based cardiovascular pharmaceuticals; Antibody-based contraceptive films; Oral, systemic and topical contraceptives; Antibody-based pharmaceutical products for use in preventing and treating infectious diseases

10 Contraceptive apparatus; Intra uterine contraceptive devices; Contraceptive vaginal rings; Medical apparatus for introducing pharmaceutical preparations into the human body

42 Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, viral and infectious diseases, cancer, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, contraceptives, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices; medical and scientific research, namely, conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Pharmaceutical research and development in relation to infectious disease prevention and therapy

Trademark Events

Mar 16, 2020

Abandonment Notice Mailed - No Use Statement Filed

Mar 16, 2020

Abandonment - No Use Statement Filed

Aug 13, 2019

Noa Mailed - Sou Required From Applicant

Jun 18, 2019

Published For Opposition

May 29, 2019

Notice Of Publication

May 15, 2019

Approved For Pub - Principal Register

May 8, 2019

Assigned To Examiner

Mar 21, 2019

New Application Office Supplied Data Entered In Tram

Mar 1, 2019

New Application Entered In Tram